A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
Snow causes road closures and event cancellations
Icy start to the new week. Turning milder and more unsettled. The big thaw sets in...
We asked for your best snowy shots from Sunday's whiteout across the North West. Here's just a few of them.